Palvella Therapeutics (PVLA) Treasury Shares (2014 - 2024)

Palvella Therapeutics (PVLA) has 5 years of Treasury Shares data on file, last reported at $15.4 million in Q3 2024.

• On a quarterly basis, Treasury Shares changed N/A year-over-year to $15.4 million in Q3 2024; TTM through Sep 2024 was $15.4 million, a N/A change from a year earlier, with the FY2023 full-year figure at $15.4 million, changed 0.0% from the prior year.
• Treasury Shares for Q3 2024 stood at $15.4 million, roughly flat from $15.4 million in the prior quarter.
• Over the last five years, Treasury Shares for PVLA reached as high as $15.4 million in Q4 2022 and fell as low as $15.4 million in Q4 2022.
• Historically, Treasury Shares has averaged $15.4 million across 3 years, with a median of $15.4 million in 2022.
• On a YoY basis, Treasury Shares climbed as much as 0.0% in 2023 and fell as far as 0.0% in 2023.
• Year by year, Treasury Shares stood at $15.4 million in 2022, then changed by 0.0% to $15.4 million in 2023, then changed by 0.0% to $15.4 million in 2024.
• Per Business Quant data, the three most recent Treasury Shares figures were $15.4 million in Q3 2024, $15.4 million in Q2 2024, and $15.4 million in Q1 2024.